Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00574717 · ClinicalTrials.gov registry record · Phase 1
Enhancement of Emmetropization in Hyperopic Infants
A Phase 1 study, sponsored by Ohio State University.
- Terminated
- Registry status
- Phase 1
- Development phase
- 6
- Enrollment target
NCT00574717: Clinical Trial Phase 1 study, sponsored by Ohio State University.
NCT00574717 is a Phase 1 study that was terminated before completion, run by Ohio State University. The registered enrollment target is 6 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00574717, a Phase 1 study, was terminated before completion, sponsored by Ohio State University.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
To determine if wearing a moderate spectacle under-correction (3.00D) and performing activities designed to stimulate accurate accommodation during a 15-month period will enhance emmetropization in highly hyperopic (between +5.00D and +7.00D) 3-month old infants.
Interventions
- PROCEDURE Spectacles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2007-12 |
| Est. Completion | 2010-09 |
| Phase | Phase 1 |
Why NCT00574717 stopped before completion
NCT00574717 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 1 intervention - of which Spectacles is the first listed.
NCT00574717 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00574717 about?
NCT00574717 is a clinical study titled "Enhancement of Emmetropization in Hyperopic Infants". To determine if wearing a moderate spectacle under-correction (3.00D) and performing activities designed to stimulate accurate accommodation during a 15-month period will enhance emmetropization in highly hyperopic (between +5.00D and +7.00D) 3-month old infants.
What is the current status of trial NCT00574717?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2007-12. Estimated completion is 2010-09.
What interventions are being tested in trial NCT00574717?
The interventions under investigation include: Spectacles (PROCEDURE).
Who is sponsoring clinical trial NCT00574717?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00574717's enrollment target sits among peer trials
6 1974th of 2000 higher than 12 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia